CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO Perspective
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top investment pockets
3.2.2 Top winning strategies
3.3 Porters five forces analysis
3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of new entrants
3.3.4 Threat of substitutes
3.3.5 Competitive rivalry
3.4 Market dynamics
3.4.1 Drivers
3.4.1.1 Rise in geriatric population
3.4.1.2 Rise in prevalence of cardiovascular and orthopedic disorders
3.4.1.3 Rising demand for implantable devices
3.4.1.4 Advancements in medical technology
3.4.1.5 Advantages of biomaterials products
3.4.1.6 Heavy funding by government agencies
3.4.2 Restraints
3.4.2.1 High cost of biomaterial production
3.4.2.2 Compatibility issues
3.4.2.3 Difficulty in wearing the products
3.4.3 Opportunities
3.4.3.1 Introduction of decellularized dermal matrixes for grafting and hydrogel scaffolding
3.4.3.2 Introduction of new products in plastic surgery, wound healing, and neurology sector
CHAPTER 4 WORLD BIOMATERIALS MARKET, BY TYPE, 2014-2022
4.1 Overview
4.1.1 Market size and forecast
4.2 Metallic
4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.2.4 Stainless steel
4.2.6 Titanium & titanium alloys
4.2.8 Cobalt-chrome alloys
4.2.10 Gold
4.2.12 Silver
4.3 Polymeric
4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.3.4 Polymethylmethacrylate (PMMA)
4.3.6 Polyethylene
4.3.8 Polyester
4.3.10 Polyvinylchloride
4.3.12 Silicone rubber
4.3.14 Nylon
4.3.16 Polyetheretherketone
4.4 Ceramic
4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast
4.4.4 Calcium phosphate
4.4.5 Calcium phosphate market size & forecast
4.4.6 Zirconia
4.4.8 Aluminum oxide
4.4.10 Calcium sulfate
4.4.12 Carbon
4.4.14 Glass
4.5 Natural
4.5.1 Key market trends
4.5.2 Key growth factors and opportunities
4.5.1 Market size and forecast
4.5.2 Hyaluronic acid
4.5.4 Collagen & gelatin
4.5.6 Fibrin
4.5.8 Cellulose
4.5.10 Chitin
4.5.12 Alginates
4.5.14 Silk
CHAPTER 5 WORLD BIOMATERIALS MARKET, BY APPLICATION, 2014-2022
5.1 Overview
5.1.1 Market size and forecast
5.2 Cardiovascular
5.2.1 Market size and forecast
5.3 Dental
5.3.1 Market size and forecast
5.4 Orthopedic
5.4.1 Market size and forecast
5.5 Wound healing
5.5.1 Market size and forecast
5.6 Plastic surgery
5.6.1 Market size and forecast
5.7 Ophthalmology
5.7.1 Market size and forecast
5.8 Tissue engineering
5.8.1 Market size and forecast
5.9 Neurological disorders
5.9.1 Market size and forecast
5.10 Drug delivery systems
5.10.1 Market size and forecast
CHAPTER 6 WORLD BIOMATERIALS MARKET, BY GEOGRAPHY, 2014-2022
6.1 Overview
6.1.1 Market size and forecast
6.1 North America
6.1.1 Key market trends
6.1.2 Key growth factors and opportunities
6.1.3 Market size and forecast
6.1.4 U.S. market size and forecast
6.1.5 Canada market size and forecast
6.1.6 Mexico market size and forecast
6.2 Europe
6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.2.4 Germany market size and forecast
6.2.5 France market size and forecast
6.2.6 U.K. market size and forecast
6.2.7 Italy market size and forecast
6.2.8 Spain market size and forecast
6.2.9 Russia market size and forecast
6.2.10 Others market size and forecast
6.3 Asia-Pacific
6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.3.4 Japan market size and forecast
6.3.5 China market size and forecast
6.3.6 Australia market size and forecast
6.3.7 India market size and forecast
6.3.8 South Korea market size and forecast
6.3.9 Taiwan market size and forecast
6.3.10 Others market size and forecast
6.4 LAMEA
6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
6.4.4 Brazil market size and forecast
6.4.5 Turkey market size and forecast
6.4.6 Venezuela market size and forecast
6.4.7 Saudi Arabia market size and forecast
6.4.8 Republic of South Africa market size and forecast
6.4.9 Others market size and forecast
CHAPTER 7 COMPANY PROFILES
7.1 Royal DSM
7.1.1 Company overview
7.1.2 Operating business segments
7.1.3 Business performance
7.1.4 Key strategic moves & developments
7.2 Wright Medical Group N.V.
7.2.1 Company overview
7.2.2 Operating business segments
7.2.3 Business performance
7.2.4 Key strategic moves & developments
7.3 Corbion N.V.
7.3.1 Company overview
7.3.2 Operating business segments
7.3.3 Business performance
7.3.4 Key strategic moves & developments
7.4 Zimmer Biomet Holdings, Inc.
7.4.1 Company overview
7.4.2 Operating business segments
7.4.3 Business performance
7.4.4 Key strategic moves & developments
7.5 Bayer AG
7.5.1 Company overview
7.5.2 Operating business segments
7.5.3 Business performance
7.6 Carpenter Technology Corporation
7.6.1 Company overview
7.6.2 Operating business segments
7.6.3 Business performance
7.7 Covalon Technologies Ltd.
7.7.1 Company overview
7.7.2 Operating business segments
7.7.3 Business performance
7.8 Evonik Industries AG
7.8.1 Company overview
7.8.2 Operating business segments
7.8.3 Business performance
7.8.4 Key strategic moves & developments
7.9 BASF SE
7.9.1 Company overview
7.9.2 Operating business segments
7.9.3 Business performance
7.10 Victrex plc.
7.10.1 Company overview
7.10.2 Operating business segments
7.10.3 Business performance
7.10.4 Key strategic moves & developments
7.11 Collagen Matrix, Inc.
7.11.1 Company overview
7.11.2 Operating business segments